DiaMedica Therapeutics, Inc. (DMAC)
8.42
-0.21
(-2.43%)
USD |
NASDAQ |
Oct 23, 10:27
DiaMedica Therapeutics Price to Book Value : 11.84 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 22, 2026 | 12.14 |
| October 21, 2026 | 12.22 |
| October 20, 2026 | 12.20 |
| October 19, 2026 | 11.07 |
| October 16, 2026 | 10.65 |
| October 15, 2026 | 11.31 |
| October 14, 2026 | 10.77 |
| October 13, 2026 | 11.00 |
| October 12, 2026 | 11.53 |
| October 09, 2026 | 11.72 |
| October 08, 2026 | 11.27 |
| October 07, 2026 | 11.24 |
| October 06, 2026 | 11.44 |
| October 05, 2026 | 11.84 |
| October 02, 2026 | 11.58 |
| October 01, 2026 | 11.74 |
| September 30, 2026 | 11.63 |
| September 29, 2026 | 11.53 |
| September 28, 2026 | 11.70 |
| September 25, 2026 | 11.17 |
| September 24, 2026 | 11.01 |
| September 23, 2026 | 10.63 |
| September 22, 2026 | 10.94 |
| September 21, 2026 | 10.21 |
| September 18, 2026 | 9.635 |
| Date | Value |
|---|---|
| September 17, 2026 | 9.635 |
| September 16, 2026 | 9.326 |
| September 15, 2026 | 9.185 |
| September 14, 2026 | 9.213 |
| September 11, 2026 | 9.101 |
| September 10, 2026 | 9.101 |
| September 09, 2026 | 9.269 |
| September 08, 2026 | 9.199 |
| September 04, 2026 | 9.494 |
| September 03, 2026 | 9.227 |
| September 02, 2026 | 9.494 |
| September 01, 2026 | 9.072 |
| August 31, 2026 | 8.932 |
| August 28, 2026 | 8.988 |
| August 27, 2026 | 9.494 |
| August 26, 2026 | 9.424 |
| August 25, 2026 | 9.480 |
| August 24, 2026 | 9.171 |
| August 21, 2026 | 9.171 |
| August 20, 2026 | 9.171 |
| August 19, 2026 | 9.579 |
| August 18, 2026 | 9.298 |
| August 17, 2026 | 9.312 |
| August 14, 2026 | 9.396 |
| August 13, 2026 | 9.494 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.604 |
| Alnylam Pharmaceuticals, Inc. | 22.14 |
| Anika Therapeutics, Inc. | 2.056 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.887 |
Price to Book Value Related Metrics
| PEG Ratio | -3.435 |
| Price | 8.42 |
| Earnings Yield | -8.48% |
| Market Cap | 454.05M |
| PEGY Ratio | -3.435 |